Masjedi MR - Search Results

1

Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran.

Tabarsi P, Baghaei P, Mirsaeidi M, Amiri M, Alipanah N, Emami H, Novin A, Mansouri D, Masjedi MR, Velayati AA. Tabarsi P, et al. Among authors: masjedi mr. Saudi Med J. 2008 Jan;29(1):148-50. Saudi Med J. 2008. PMID: 18176695 No abstract available.

2

Mycobacterial infection and the impact of rifabutin treatment in organ transplant recipients: a single-center study.

Tabarsi P, Farshidpour M, Marjani M, Baghaei P, Yousefzadeh A, Najafizadeh K, Sharifkashani B, Javanmard P, Mansouri D, Masjedi M, Velayati A. Tabarsi P, et al. Saudi J Kidney Dis Transpl. 2015 Jan;26(1):6-11. doi: 10.4103/1319-2442.148710. Saudi J Kidney Dis Transpl. 2015. PMID: 25579709

3

Trends of drug resistant Mycobacterium tuberculosis in a tertiary tuberculosis center in Iran.

Mirsaeidi MS, Tabarsi P, Farnia P, Ebrahimi G, Morris MW, Masjedi MR, Velayati AA, Mansouri D. Mirsaeidi MS, et al. Among authors: masjedi mr. Saudi Med J. 2007 Apr;28(4):544-50. Saudi Med J. 2007. PMID: 17457475

4

Extensively drug-resistant tuberculosis treatment outcome in Iran: a case series of seven patients.

Masjedi MR, Tabarsi P, Baghaei P, Jalali S, Farnia P, Chitsaz E, Amiri M, Mansouri D, Velayati AA. Masjedi MR, et al. Int J Infect Dis. 2010 May;14(5):e399-402. doi: 10.1016/j.ijid.2009.07.002. Epub 2009 Oct 8. Int J Infect Dis. 2010. PMID: 19818664 Free article.

5

First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran.

Tabarsi P, Chitsaz E, Moradi A, Baghaei P, Farnia P, Marjani M, Irannejad P, Mansouri D, Masjedi M. Tabarsi P, et al. Int J STD AIDS. 2009 Aug;20(8):566-70. doi: 10.1258/ijsa.2008.008379. Int J STD AIDS. 2009. PMID: 19625590

6

Standardised second-line treatment of multidrug-resistant tuberculosis during pregnancy.

Tabarsi P, Moradi A, Baghaei P, Marjani M, Shamaei M, Mansouri N, Chitsaz E, Farnia P, Mansouri D, Masjedi M, Velayati A. Tabarsi P, et al. Int J Tuberc Lung Dis. 2011 Apr;15(4):547-50. doi: 10.5588/ijtld.10.0140. Int J Tuberc Lung Dis. 2011. PMID: 21396217

7

Treatment outcome, mortality and their predictors among HIV-associated tuberculosis patients.

Tabarsi P, Chitsaz E, Moradi A, Baghaei P, Farnia P, Marjani M, Shamai M, Amiri M, Nikaein S, Mansouri D, Masjedi M, Altice F. Tabarsi P, et al. Int J STD AIDS. 2012 Sep;23(9):e1-4. doi: 10.1258/ijsa.2009.009093. Int J STD AIDS. 2012. PMID: 23033530 Free PMC article.

8

Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases.

Baghaei P, Tabarsi P, Chitsaz E, Saleh M, Marjani M, Shemirani S, Pooramiri MV, Kazempour M, Farnia P, Fahimi F, Mansouri D, Masjedi M. Baghaei P, et al. Am J Ther. 2010 Jan-Feb;17(1):17-22. doi: 10.1097/MJT.0b013e31818f9eae. Am J Ther. 2010. PMID: 19535968

9

Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran.

Baghaei P, Tabarsi P, Dorriz D, Marjani M, Shamaei M, Pooramiri MV, Mansouri D, Farnia P, Masjedi M, Velayati A. Baghaei P, et al. Am J Ther. 2011 Mar-Apr;18(2):e29-34. doi: 10.1097/MJT.0b013e3181c0806d. Am J Ther. 2011. PMID: 20019591

10

Prevalence of Oseltamivir-Resistant 2009 H1N1 Influenza Virus among Patients with Pandemic 2009 H1N1 Influenza infection in NRITLD, Tehran, Iran.

Moradi A, Nadji SA, Tabarsi P, Hashemian SM, Marjani M, Sigaroodi A, Mansouri D, Masjedi M, Velayati AA. Moradi A, et al. Tanaffos. 2011;10(1):8-11. Tanaffos. 2011. PMID: 25191344 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters